Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Examination of effect of yokukansan in prevention of the delirium after the surgical operation.

Next Previous
Trial Profile

Examination of effect of yokukansan in prevention of the delirium after the surgical operation.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 22 Feb 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs TJ 54 (Primary)
  • Indications Delirium
  • Focus Adverse reactions; Therapeutic Use

Most Recent Events

  • 20 Jan 2018 Results of an exploratory analysis assessing the incidence and risk factors of postoperative delirium after gastrointestinal surgery, presented at the 2018 Gastrointestinal Cancers Symposium
  • 21 Jan 2017 Primary endpoint (Postoperative delirium incidence) has not been met.
  • 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top